Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 2003

View Archived Issues

CHF-3381, a potential new therapy for peripheral painful neuropathies

Squalene synthase inhibitor TAK-475 may have therapeutic potential in dyslipidemia

RWJ-58643, a tryptase inhibitor with potential antiasthmatic activity

JIMB-01, a microtubule-modifying agent, has antiproliferative properties in human malignant tumors

PSA-activated thapsigargin prodrug as a specific agent for prostate cancer

Adenosine A2A receptor antagonist benefits patients with Parkinson's disease

Fluconazole effective in treating early septic shock

Melagatran combined with ximelagatran may be effective in preventing postoperative thromboembolism

New MEK inhibitors and their use patented

GSK scientists present novel 5-HT6 ligands for psychosis, depression, anxiety, etc.

New beta4-selective acetylcholine receptor modulators under study at Lilly

Pyrimidine-based NS5B inhibitors newly discovered by Italian team

New HIV integrase inhibitors in early development at Merck

Novel erythromycin antibiotics designed by Kosan scientists

Daiichi discontinues development of DE-310

New warnings added to Zenapax labeling

Alert issued on Reyataz in combination with Viread

MacroChem expands phase II Topiglan trial into U.S.

FDA grants orphan drug designation for Fidelin

Highlights in psychogeriatrics

New phase I/II trial to evaluate Xcellerated T Cells in treatment of CLL

Once-daily Cipro XR approved for treatment of cUTIs

Nabi submits supplemental data for Nabi-HB Intravenous BLA

Wellbutrin XL approved for major depressive disorder

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...